November 4, 2008, Vancouver, BC — Digital Payment Technologies Corp. (DPT), a leading supplier of advanced multi-space parking meters and revenue-management solutions for the global parking industry, is pleased to announce a $3,000,000 investment and conditional commitment for an additional $3,000,000 into the company by C.A. Bancorp Inc. (TSX: BKP) (“C.A. Bancorp”)
VANCOUVER, Oct. 14 - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) (the "Company") today announced that it has entered into an agreement with Haywood Securities Inc., as agent, pursuant to which the Company has agreed to offer for sale, on a best efforts basis and by private placement, an aggregate of 30,555,556 units at a price of $0.18 per unit, each unit consisting of one common share and one-half of one common share purchase warrant, for gross proceeds of approximately $5.5 million.
BDC Venture Capital and GrowthWorks Capital confirm commitment to multiple award-winning 'office-in-a-box' solution
June 3, 2008, Vancouver, B.C.- Sutus Inc., the company behind the Sutus Business Central™, a unique all-in-one device that combines all IT data communications and Telephony features required to run a modern-day office, today announced it has secured $5 million in funding from BDC Venture Capital and GrowthWorks Capital. The funding will be used for sales and channel expansion as the company continues to grow since launching its flagship product in late 2007.
March 14, 2008 - enGene Inc., a privately held biotechnology company developing an innovative approach for the treatment of diabetes called GEMSTM-Insulin, announced today it has raised US$6.4 million in a Series A financing, consisting of new investment and conversion of an existing convertible note financing. The financing was led by Saad Investments Company Ltd. and included Masa Life Science Ventures LP (MLSV) of Washington, DC and private investors.
March 14, 2008 - Officials from the Government of Canada, EnCana Corporation (TSX, NYSE: ECA) and Sustainable Development Technology Canada (SDTC) announced today they are committing $5.5 million in financing to a NxtGen Emission Controls project which demonstrates an innovative diesel emission reduction system. NxtGen’s syngas technology will assist diesel trucks in complying with stringent global emission reduction regulations and has the potential to enable manufacturers to increase fuel economy.
Vancouver, British Columbia, November 20, 2007 – Protox Therapeutics Inc. (TSX-V: PRX), a leader in advancing, targeted toxin therapeutics for the treatment of cancer and other proliferative diseases, announced today that it has received approximately $7.6 million of a potential $7.7 million from the exercise of warrants issued as a result of the two tranches of a unit private placement financing closed on November 4 and 17, 2005. Any remaining warrants relating to this financing have now expired. This brings the current cash position of the Company to just over $12 million.
wavefront(tm) to Provide Services to Catalyze Wireless Developer Marketplace
The government of the province of British Columbia has shown its strong support of the wireless industry in BC through its recent funding of wavefront. The Ministry of Advanced Education has provided $5 million in funding to help wavefront with startup and operational costs. wavefront will provide testing and commercialization services to the wireless developer community.
Vancouver, British Columbia, October 26, 2007 – Protox Therapeutics Inc. (TSX-V:PRX), a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases, announced today that it has already received a total of approximately $5.2 million of a potential $7.7 million from the exercise of warrants issued as a result of the two tranches of a private placement financing dated November 4 and 17, 2005. This brings the approximate current cash position of the Company to just over $10.0 million.
VANCOUVER, B.C. July 30, 2007 - MetroBridge Networks International Inc., a premier high-speed wireless broadband provider for business in British Columbia with operations in Arizona, is pleased to announce that it has successfully completed the reverse take over of Huntingdon Capital Inc.
Vancouver, BC, May 28, 2007--(T-Net)--The Centre for Drug Research and Development, a unique hybrid organization that helps health researchers collaborate, refine their discoveries and develop them for commercial use, received an additional $8 million in funding for its core facility. This investment matches the $8 million Canada Foundation for Innovation (CFI) grant CDRD received last November. It also comes on the heels of a $25 million funding grant from the Province of BC announced last month by Premier Gordon Campbell at the 2007 British Columbia Life Sciences Awards.